threonine has been researched along with oxidopamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, Q; He, Y; Tan, L; Zhan, Q | 1 |
Greene, LA; Jin, ZH; Malagelada, C | 1 |
2 other study(ies) available for threonine and oxidopamine
Article | Year |
---|---|
Changes in the prodynorphin gene and DARPP-32 state in 6-OHDA-lesioned rats following long-term treatment with l-dopa.
Topics: Amino Acid Sequence; Animals; Basal Ganglia; Brain Chemistry; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Administration Schedule; Dyskinesia, Drug-Induced; Enkephalins; Excitatory Amino Acid Antagonists; Female; Gene Expression Regulation; Levodopa; Male; Neural Pathways; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Threonine; Time | 2007 |
RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation.
Topics: Analysis of Variance; Animals; Animals, Newborn; Cell Death; Cells, Cultured; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Melanins; Neurons; Oncogene Protein v-akt; Oxidopamine; Parkinson Disease; Phosphorylation; Rats; Serine; Substantia Nigra; Superior Cervical Ganglion; Sympatholytics; Threonine; Time Factors; Transcription Factors; Transfection | 2008 |